# CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
> **ANDA214688** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2023-03-21
## Drug
- **FDA Application Number:** ANDA214688
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Generic name:** Betamethasone Dipropionate
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** AEROSOL, FOAM
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** GLENMARK PHARMS LTD
- **First approval:** 2023-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214688)
---
*AI Analytics · CC0 1.0*